Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027
... is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 3.3 billion by 2027, at a CAGR of 20.8% during the forecast period. Factors such as technological advancements in ... Read More
-
Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery
... provides the strategists; marketers and senior management with the critical information they need to assess the global coronavirus (COVID-19) current therapy market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a ... Read More
-
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Recombinant DNA (rDNA) technology is a novel technique that has led to advances in a number of ... Read More
-
Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change
... The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in drug discovery market as it emerges from the COVID 19 ... Read More
-
Scaffold Technology Market By Product Type (Natural Scaffold, Sythetic Scaffold), By Type (Macro-Porous Scaffolds, Micro-Porous Scaffolds, Nano-Porous Scaffolds, Solid Scaffolds), By Application (Cancer cell research, Stem cell research, Drug discovery, Regenerative medicine), By End User (Biotechnology & pharmaceutical companies, Contract Research laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
... (Biotechnology & pharmaceutical companies, Contract Research laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global scaffold technology market was valued at $1,026.0 million in 2021, and is projected to reach $5,095.3 million ... Read More
-
AI for Drug Discovery Market By Offering (Software, Services);By Technology (Machine Learning and Other Technologies); By Drug Type (Small Molecule and Large Molecules); By Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases and Other Applications); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes)and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030
... By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes)and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030 Market Overview ... Read More
-
Global AI in Healthcare Market, By Offering (Software v/s Hardware), By Technology (Machine Learning, Computer Vision, Natural Language Processing, Context-Aware Computing), By Application (Medical Imaging & Diagnostics, Robotic Surgeries, Drug Discovery, Inpatient Care & Hospital Management, Patient Data & Risk Analysis, Others), By End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Patients, Others) By Region, Competition Forecast & Opportunities, 2027
... Management, Patient Data & Risk Analysis, Others), By End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Patients, Others) By Region, Competition Forecast & Opportunities, 2027 Global AI in healthcare market was valued at USD8231.36 million, ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
... 2022, with scores increased for several companies. This includes Merck & Co, whose score increased to 4 due to an increase in forecasted sales for several Phase II candidates, including its oncolytic vaccine Cavatak (gebasaxturev), ... Read More
-
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... or CD194 or CCR4) – C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor ... Read More
-
Calcitonin Gene Related Peptide (CGRP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... is a member of the calcitonin family of peptides. It exists in two forms alpha-CGRP and beta-CGRP. CGRP is produced in both peripheral and central neurons. CGRP is derived mainly from the cell bodies of ... Read More
-
Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... According to the recently published report 'Nicotinamide Phosphoribosyl transferase – Drugs In Development, 2022'; Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) pipeline Target constitutes close to ... Read More
-
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) – Myc (c-Myc) protein encoded by Myc gene, a regulator gene that code for a ... Read More
-
Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 15 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The latest report Heparanase – Drugs In ... Read More
-
Mice Model Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid Mice, Surgically Modified Mice, and Spontaneous Mutant Mice), Service (Breeding, Cryopreservation, Model-in Licensing, Genetic Testing, Quarantine, and Others), Technology (CRISPR, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, and Others), Indication [Oncology Studies, Immunology & Inflammation Studies, Endocrine Metabolic Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Genetic Studies, Infectious Disease Studies, Fibrosis, and Other Disease Studies], End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Application (Preclinical Drug Development, Biomarker Analysis, and Basic Cancer Research), and Mode (In-House and Outsourced)
... Genetic Testing, Quarantine, and Others), Technology (CRISPR, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, and Others), Indication [Oncology Studies, Immunology & Inflammation Studies, Endocrine Metabolic Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Genetic Studies, ... Read More
-
Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Protein I or CETP) pipeline Target constitutes close to 6 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the universities/institutes. The latest report Cholesteryl Ester Transfer Protein – Drugs ... Read More
-
Next Generation Sequencing Market, by Technology (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, and Others), by Application (Drug Discovery, Personalized Medicine and Genetic Screening, Disease Diagnosis, Agriculture and Animal Research, and Others), by End User (Hospital, Research Centers, Pharma and Biotech Firms, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospital, Research Centers, Pharma and Biotech Firms, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Global Liquid Handling System Market Size study, by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), by Type (Electronic Liquid Handling Systems, Automated Liquid Handling Systems, Manual Liquid Handling Systems) by Application (Drug Discovery, Genomics, Clinical Diagnostics, Proteomics, Other Applications) by End User (Biotechnology & Pharmaceutical Companies, Research Institutes, Hospital & Diagnostic Laboratories, Academic Institutes, Other End Users) and Regional Forecasts 2022-2028
... by Application (Drug Discovery, Genomics, Clinical Diagnostics, Proteomics, Other Applications) by End User (Biotechnology & Pharmaceutical Companies, Research Institutes, Hospital & Diagnostic Laboratories, Academic Institutes, Other End Users) and Regional Forecasts 2022-2028 Global Liquid Handling ... Read More
-
Artificial Intelligence (AI) in Drug Discovery - Thematic Research
... advances has led to more interest in the use of artificial intelligence (AI) and big data analytics across the pharma value chain, from drug discovery and clinical trial design, right through to sales and marketing. ... Read More
-
Growth Opportunities in AI for Drug Target Discovery and Validation
... close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (proteins/genes) have ... Read More
-
DNA Extraction Kit Market – Global Outlook & Forecast 2022-2027
... DNA and the IT infrastructure to use it. The impacts are large in the healthcare segment. The recent advancements faster cancer detection, potentially saving thousands of lives globally. Genomic innovations based on DNA have evolved ... Read More
-
Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... provides the strategists; marketers and senior management with the critical information they need to assess the global coronavirus (COVID-19) current therapy market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain ... Read More
-
Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027
... global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market ... Read More
-
Artificial Intelligence ( AI ) in Drug Discovery Market by Offering (Software, Service), Technology (Machine Learning, Deep Learning), Application (Cardiovascular, Metabolic, Neurodegenerative), End User (Pharma, Biotech,CROs) - Global Forecasts ( 2022 - 2027 )
... Artificial intelligence/AI in drug discovery Market is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7% during the forecast period. The growth of this market ... Read More
-
Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032
... to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The Rising ... Read More
-
Global Artificial Intelligence (AI) Market in Healthcare Sector 2022-2026
... a CAGR of 29.16% during the forecast period. Our report on the artificial intelligence (AI) market in healthcare sector provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as ... Read More
Research Assistance
